A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over ...

Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Embecta Corp. (“Embecta” or the “Company”) (NASDAQ: EMBC) investors of the ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Embecta Corp.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Embecta Corp. (“Embecta” or ...

View Embecta Corporation EMBC stock quote prices, financial information, real-time forecasts, and company news from CNN.

On May 5, 2026, Embecta released its second quarter fiscal 2026 financial results, revealing that revenue had declined over 14%, largely due to weakness in its pen needle sales. Additionally, the ...

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN EMBECTA CORP. (EMBC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Embecta Corp. (NASDAQ:EMBC) posted on Friday the second-quarter 2025 adjusted earnings of 70 cents per share, up from 67 cents a year ago, beating the consensus of 53 cents. The diabetes care company ...

As of April 2, 2025, the average one-year price target for Embecta is $21.47/share. The forecasts range from a low of $18.38 to a high of $27.30. The average price target represents an increase of ...